Dementia Is Rare in Amazonian Indigenous Groups, but Survival Tells a Different Story

In the remote river networks of the Bolivian Amazon, two Indigenous peoples, the Tsimané and the Mosetén, have long fascinated scientists because they appear to age differently from the rest of humanity. They walk long distances to farm, hunt and fish, they eat diets low in processed foods, and earlier studies showed that their brains atrophy less with age than the brains of people in the United States and Europe. Their hearts, too, seemed remarkably resilient. Against that backdrop, one statistic stood out: dementia appeared to be strikingly uncommon among them. A new longitudinal study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, now reveals that this familiar picture is incomplete, and that the real story lies in the difference between how often a disease begins and how long people live with it.

The research, led by Margaret Gatz, a professor of psychology and gerontology at the University of Southern California and a senior scientist at the USC Center for Economic and Social Research, followed 730 adults who were free of dementia at their initial assessment. Nearly five years later, the teams returned to re-examine the same individuals. Over that interval, they identified 22 new cases of dementia, corresponding to an overall incidence of 7.40 cases per 1,000 person-years. At the follow-up assessments, the prevalence of dementia, meaning the proportion of the population living with the condition at any given moment, remained below two percent. Those numbers seem to confirm the impression of extraordinary brain health, but the comparison with industrialized nations is more nuanced than it first appears.

The crucial distinction is between incidence and prevalence, two measures that are often conflated in popular reporting. Incidence counts the new diagnoses that arise within a defined span of time, while prevalence includes everyone living with a disease regardless of when it began. Because prevalence is shaped both by how frequently a disease develops and by how long patients survive after it develops, a one-time snapshot can be deeply misleading. A population can show very low prevalence not because its members rarely develop a disease, but because those who do develop it do not survive long enough to be counted. Repeated assessments over time, as in the new study, are what allow researchers to separate these two forces.

When the researchers made that separation, the surprising result emerged. Among the Tsimané and Mosetén, dementia incidence did not dramatically differ from rates observed in U.S. and northern European populations, particularly for individuals under the age of 80. What differed sharply was survival. Participants with dementia faced more than six times the mortality risk of those with normal cognition, and compared with U.S. studies, the average survival time following a dementia diagnosis appeared two to three times shorter. Shorter survival after dementia develops, the authors conclude, plays a significant role in why the total proportion of people living with dementia in these communities is unusually low. The disease is not so much absent as it is rapidly fatal.

The reasons for that shortened survival are rooted in the realities of life in remote Amazonian communities. Households depend on every member contributing to farming, hunting, fishing and food preparation, so a person whose disabilities prevent them from helping to obtain food simultaneously increases the burden on the family while losing their own role and support. Gatz noted that limited access to medical care means that treatable infections and other acute illnesses can become deadly, a vulnerability that is compounded for someone already weakened by dementia. In industrialized settings, by contrast, formal caregiving systems, clinical services and social safety nets extend survival for people with cognitive impairment, inflating prevalence even where incidence is similar.

The findings complicate, without fully overturning, the earlier hypothesis that the Tsimané and Mosetén are protected by their pre-industrial lifestyle. Previous work by the Tsimané Health and Life History Project, a long-running collaboration that has studied these communities for decades, found that they experience less brain atrophy and better cardiovascular health than industrialized populations, which the authors at the time attributed in part to large amounts of physical activity and healthier food from a subsistence way of life. The new data suggest that healthy hearts do not guarantee healthy brains, and that the pathways leading to dementia in this population may run along routes quite different from the ones familiar in Western medicine.

Indeed, the dementia observed in the Bolivian communities may differ biologically from prototypical Alzheimer’s disease. Many affected participants showed more difficulty with attention, reasoning and the management of everyday tasks than with memory, which is the hallmark challenge of Alzheimer’s. Preliminary blood analyses found associations between dementia cases and the amount of neurofilament light chain proteins in the blood, a general indicator of neurodegeneration, but not with the amyloid or phosphorylated tau protein profiles that are characteristic of Alzheimer’s pathology. Imaging and vascular measures suggested contributions from disease of the blood vessels. In most Tsimané with cognitive impairment or dementia, Gatz explained, the pattern of brain atrophy is not typical of Alzheimer’s disease; rather, there are changes indicative of vascular contributions to cognitive impairment and dementia.

Genetics added a further layer of complexity. The APOE e4 gene variant, the best-known genetic risk factor for Alzheimer’s disease, was associated with dementia in the study. Yet Gatz cautioned that APOE4 also influences lipid transport and immune response, so the association does not necessarily establish Alzheimer’s pathology. Disentangling how lifestyle and genetic factors interact in this population will require far more data, she said, noting that the two are generally believed to play complementary roles. The methodological effort itself was substantial: the researchers adapted clinical interviews and cognitive tests for language, culture and limited literacy, conducting assessments in Tsimané or Spanish, while the project’s teams also provide medical examinations and help coordinate care for participants.

The study’s authors are careful about the limits of their data. With only 22 cases, they caution that the numbers are too few to fully discern all of the factors behind the community’s low prevalence. Even so, the work adds rare incidence data to dementia research among Indigenous peoples, a field where such longitudinal evidence is scarce. Some Indigenous communities report high dementia prevalence following disruptive integration into dominant societies and greater exposure to chronic disease risks, while several Indigenous and rural populations retaining subsistence lifestyles report low prevalence. Gatz framed this contrast as an important health-equity challenge, and Hillard Kaplan, a health economist at Chapman University and principal investigator of the Tsimané Health and Life History Project, said the findings indicate that brain aging occurs without significant heart disease and that much more remains to be learned about the pathways leading to dementia. Future phases of the research will deploy improved brain imaging and additional blood biomarkers to investigate vascular injury and Alzheimer’s pathology, work that Gatz described as immensely challenging and highly rewarding, and for which the research team remains grateful for the communities’ participation.

Subject of Research: Dementia incidence, survival and prevalence in two Indigenous Bolivian populations living pre-industrial lifestyles

Article Title: New study sheds light on dementia among Indigenous Bolivians

Article References: New study sheds light on dementia among Indigenous Bolivians. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: dementia, Tsimané, Mosetén, Bolivia, Indigenous health, incidence, prevalence, vascular cognitive impairment, APOE4, neurofilament light chain, Alzheimer's disease, longitudinal study